
Discover the challenges and opportunities of acquiring an Amazon FBA supplements business in this engaging episode with special guest Travis Jamison.
Discover the challenges and opportunities of acquiring an Amazon FBA supplements business in this engaging episode with special guest Travis Jamison.
This episode is brought to you by our sponsors:
Capital Pad: Your platform for connecting investors with searcher and independent sponsor deals. Learn more at https://www.capitalpad.com.
HoldCo Conference: The premier event for holding company entrepreneurs. Don't miss your chance to connect and learn. Visit https://www.holdcoconf.com for details.
Travis Jamison joins the show to break down an Amazon FBA supplements business listed for a whopping 10x multiple. With his deep expertise in e-commerce and Amazon FBA, Travis explores the risks and rewards of buying into a highly competitive niche. We discuss supply chain strategies, the sustainability of growth claims, and why some FBA deals might not be worth the risk—plus insights into more resilient investment opportunities.
Key Highlights:
- Introduction to Travis Jamison and his e-commerce background.
- Overview of the Amazon FBA supplements business listing and its valuation.
- Insights into the cutthroat nature of Amazon's supplements niche.
- The role of pricing, branding, and operational efficiency in the business.
- Strategies for evaluating growth potential and avoiding pitfalls in acquisitions.
- Exploring alternative, stable business opportunities on platforms like Capital Pad.

A profitable multi-location mobility solutions franchise is under the microscope in this episode, with the team digging into payer mix, growth potential, and the real value of a franchise model.

In this episode, the hosts dissect a $16M listing for a crypto news media company claiming $6M in revenue—raising serious questions about valuation, legitimacy, and what the business actually does.

A $12M revenue, $3.8M EBITDA “Project Lucid” branded inspection device distributor sparks heated debate on IP risk, exclusivity with its manufacturer, and the eyebrow-raising $5M liquid funds buyer requirement.